4//SEC Filing
Burgess Julie 4
Accession 0001415889-25-000879
CIK 0001807120other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:00 PM ET
Size
5.7 KB
Accession
0001415889-25-000879
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock option (right to buy)
2025-01-02+135,000→ 135,000 totalExercise: $6.17Exp: 2035-01-01→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2026, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001883722
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:00 PM ET
- Size
- 5.7 KB